CD4+CD25+ Foxp3+ regulatory T cells protect against T cell-mediated fulminant hepatitis in a TGF-β-dependent manner in mice

Hua Xing Wei, Ya Hui Chuang, Bofeng Li, Haiming Wei, Rui Sun, Yuki Moritoki, M. Eric Gershwin, Zhe Xiong Lian, Zhigang Tian

Research output: Contribution to journalArticle

51 Citations (Scopus)

Abstract

Regulatory T cells (Tregs), which are characterized by expression of CD4, CD25, and Foxp3, play a crucial role in the control of immune responses to both self and non-self Ags. To date, there are only limited data on their role in physiological and pathological hepatic immune responses. In this study, we examined the role of hepatic Tregs in immune-mediated liver injury by using the murine Con A-induced hepatitis model. Con A treatment was associated with an increased number of Foxp3+ Tregs in liver but not in spleen. Moreover, the expression levels of Foxp3, CTLA-4, glucocorticoid-induced TNF receptor, as well as the frequency of CD103 of Tregs were increased after Con A injection, being significantly higher in liver than in spleen. Depleting CD25+ cells aggravated liver injury, whereas adoptively transferring CD25+ cells or Tregs reduced liver injury in Con A-treated recipients. Con A treatment induced elevated serum levels and hepatic mononuclear mRNA expressions of TGF-β, which were reduced by Tregs depletion. In addition, anti-TGF-β mAbs blocked the suppressive function of Tregs from Con A-treated mice in vitro. Finally, TGF-β receptor II dominant-negative mice, whose T cells express a dominant negative form of TGFβRII and therefore cannot respond to TGF-β, had a higher mortality rate and severer liver injury than normal mice injected with the same dose of Con A. These results indicate that CD4+CD25+ Tregs play an important role in limiting the liver injury in Con A-induced hepatitis via a TGF-β-dependent mechanism.

Original languageEnglish (US)
Pages (from-to)7221-7229
Number of pages9
JournalJournal of Immunology
Volume181
Issue number10
StatePublished - Nov 15 2008

Fingerprint

Regulatory T-Lymphocytes
Hepatitis
T-Lymphocytes
Liver
Wounds and Injuries
Spleen
Tumor Necrosis Factor Receptors
Glucocorticoids
Messenger RNA
Injections
Mortality

ASJC Scopus subject areas

  • Immunology
  • Medicine(all)

Cite this

Wei, H. X., Chuang, Y. H., Li, B., Wei, H., Sun, R., Moritoki, Y., ... Tian, Z. (2008). CD4+CD25+ Foxp3+ regulatory T cells protect against T cell-mediated fulminant hepatitis in a TGF-β-dependent manner in mice. Journal of Immunology, 181(10), 7221-7229.

CD4+CD25+ Foxp3+ regulatory T cells protect against T cell-mediated fulminant hepatitis in a TGF-β-dependent manner in mice. / Wei, Hua Xing; Chuang, Ya Hui; Li, Bofeng; Wei, Haiming; Sun, Rui; Moritoki, Yuki; Gershwin, M. Eric; Lian, Zhe Xiong; Tian, Zhigang.

In: Journal of Immunology, Vol. 181, No. 10, 15.11.2008, p. 7221-7229.

Research output: Contribution to journalArticle

Wei, HX, Chuang, YH, Li, B, Wei, H, Sun, R, Moritoki, Y, Gershwin, ME, Lian, ZX & Tian, Z 2008, 'CD4+CD25+ Foxp3+ regulatory T cells protect against T cell-mediated fulminant hepatitis in a TGF-β-dependent manner in mice', Journal of Immunology, vol. 181, no. 10, pp. 7221-7229.
Wei, Hua Xing ; Chuang, Ya Hui ; Li, Bofeng ; Wei, Haiming ; Sun, Rui ; Moritoki, Yuki ; Gershwin, M. Eric ; Lian, Zhe Xiong ; Tian, Zhigang. / CD4+CD25+ Foxp3+ regulatory T cells protect against T cell-mediated fulminant hepatitis in a TGF-β-dependent manner in mice. In: Journal of Immunology. 2008 ; Vol. 181, No. 10. pp. 7221-7229.
@article{bd535400735146e3b6105308ac10d612,
title = "CD4+CD25+ Foxp3+ regulatory T cells protect against T cell-mediated fulminant hepatitis in a TGF-β-dependent manner in mice",
abstract = "Regulatory T cells (Tregs), which are characterized by expression of CD4, CD25, and Foxp3, play a crucial role in the control of immune responses to both self and non-self Ags. To date, there are only limited data on their role in physiological and pathological hepatic immune responses. In this study, we examined the role of hepatic Tregs in immune-mediated liver injury by using the murine Con A-induced hepatitis model. Con A treatment was associated with an increased number of Foxp3+ Tregs in liver but not in spleen. Moreover, the expression levels of Foxp3, CTLA-4, glucocorticoid-induced TNF receptor, as well as the frequency of CD103 of Tregs were increased after Con A injection, being significantly higher in liver than in spleen. Depleting CD25+ cells aggravated liver injury, whereas adoptively transferring CD25+ cells or Tregs reduced liver injury in Con A-treated recipients. Con A treatment induced elevated serum levels and hepatic mononuclear mRNA expressions of TGF-β, which were reduced by Tregs depletion. In addition, anti-TGF-β mAbs blocked the suppressive function of Tregs from Con A-treated mice in vitro. Finally, TGF-β receptor II dominant-negative mice, whose T cells express a dominant negative form of TGFβRII and therefore cannot respond to TGF-β, had a higher mortality rate and severer liver injury than normal mice injected with the same dose of Con A. These results indicate that CD4+CD25+ Tregs play an important role in limiting the liver injury in Con A-induced hepatitis via a TGF-β-dependent mechanism.",
author = "Wei, {Hua Xing} and Chuang, {Ya Hui} and Bofeng Li and Haiming Wei and Rui Sun and Yuki Moritoki and Gershwin, {M. Eric} and Lian, {Zhe Xiong} and Zhigang Tian",
year = "2008",
month = "11",
day = "15",
language = "English (US)",
volume = "181",
pages = "7221--7229",
journal = "Journal of Immunology",
issn = "0022-1767",
publisher = "American Association of Immunologists",
number = "10",

}

TY - JOUR

T1 - CD4+CD25+ Foxp3+ regulatory T cells protect against T cell-mediated fulminant hepatitis in a TGF-β-dependent manner in mice

AU - Wei, Hua Xing

AU - Chuang, Ya Hui

AU - Li, Bofeng

AU - Wei, Haiming

AU - Sun, Rui

AU - Moritoki, Yuki

AU - Gershwin, M. Eric

AU - Lian, Zhe Xiong

AU - Tian, Zhigang

PY - 2008/11/15

Y1 - 2008/11/15

N2 - Regulatory T cells (Tregs), which are characterized by expression of CD4, CD25, and Foxp3, play a crucial role in the control of immune responses to both self and non-self Ags. To date, there are only limited data on their role in physiological and pathological hepatic immune responses. In this study, we examined the role of hepatic Tregs in immune-mediated liver injury by using the murine Con A-induced hepatitis model. Con A treatment was associated with an increased number of Foxp3+ Tregs in liver but not in spleen. Moreover, the expression levels of Foxp3, CTLA-4, glucocorticoid-induced TNF receptor, as well as the frequency of CD103 of Tregs were increased after Con A injection, being significantly higher in liver than in spleen. Depleting CD25+ cells aggravated liver injury, whereas adoptively transferring CD25+ cells or Tregs reduced liver injury in Con A-treated recipients. Con A treatment induced elevated serum levels and hepatic mononuclear mRNA expressions of TGF-β, which were reduced by Tregs depletion. In addition, anti-TGF-β mAbs blocked the suppressive function of Tregs from Con A-treated mice in vitro. Finally, TGF-β receptor II dominant-negative mice, whose T cells express a dominant negative form of TGFβRII and therefore cannot respond to TGF-β, had a higher mortality rate and severer liver injury than normal mice injected with the same dose of Con A. These results indicate that CD4+CD25+ Tregs play an important role in limiting the liver injury in Con A-induced hepatitis via a TGF-β-dependent mechanism.

AB - Regulatory T cells (Tregs), which are characterized by expression of CD4, CD25, and Foxp3, play a crucial role in the control of immune responses to both self and non-self Ags. To date, there are only limited data on their role in physiological and pathological hepatic immune responses. In this study, we examined the role of hepatic Tregs in immune-mediated liver injury by using the murine Con A-induced hepatitis model. Con A treatment was associated with an increased number of Foxp3+ Tregs in liver but not in spleen. Moreover, the expression levels of Foxp3, CTLA-4, glucocorticoid-induced TNF receptor, as well as the frequency of CD103 of Tregs were increased after Con A injection, being significantly higher in liver than in spleen. Depleting CD25+ cells aggravated liver injury, whereas adoptively transferring CD25+ cells or Tregs reduced liver injury in Con A-treated recipients. Con A treatment induced elevated serum levels and hepatic mononuclear mRNA expressions of TGF-β, which were reduced by Tregs depletion. In addition, anti-TGF-β mAbs blocked the suppressive function of Tregs from Con A-treated mice in vitro. Finally, TGF-β receptor II dominant-negative mice, whose T cells express a dominant negative form of TGFβRII and therefore cannot respond to TGF-β, had a higher mortality rate and severer liver injury than normal mice injected with the same dose of Con A. These results indicate that CD4+CD25+ Tregs play an important role in limiting the liver injury in Con A-induced hepatitis via a TGF-β-dependent mechanism.

UR - http://www.scopus.com/inward/record.url?scp=58149187111&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=58149187111&partnerID=8YFLogxK

M3 - Article

VL - 181

SP - 7221

EP - 7229

JO - Journal of Immunology

JF - Journal of Immunology

SN - 0022-1767

IS - 10

ER -